REVIEW VARIATION AND TERMINATION Sample Clauses

REVIEW VARIATION AND TERMINATION. The service specification shall be reviewed at least annually. Variation to the service specification, Competency and Training Frameworks and NECAF can only be made with the agreement of the Welsh Government. Variation to the service specification can only be made following consultation with Community Pharmacy Wales. Contractors will be notified of any variations to the service specification in writing. No variation to the specification will be made until 90 days after that notice is received. Providers, as signatories to the SLA, may cease to provide the service by giving notice in writing to the Local Health Board. Local Health Boards will require the agreement of the relevant Area Planning Board before any notice of withdrawal of the service is served. In the event of such notice the service will be terminated 90 days after that notice is received.
Sample 1Sample 2Sample 3See All (5)
AutoNDA by SimpleDocs
REVIEW VARIATION AND TERMINATION. 8.1. Variation to the service specification will only be made following consultation with Community Pharmacy Wales. 8.2. Pharmacy Contractors will be notified of any variations to the service specification in writing. No variation to the specification will be made until 90 days after that notice is received, other than where it is clinically or legally necessary to do so. 8.3. Unless agreed by both parties, the service will be funded by the health board and provided by the contractor in accordance with this service specification (or subsequent amended versions) for a period of not less than 2 years (the ‘initial period’). 8.3.1. A party seeking early termination of the service without the agreement of the second party will be liable to a termination charge equivalent to the pro-rata remaining balance of any setup costs5 incurred by the second party. (e.g. if terminated at 12 months, 50% of initial setup costs would be repaid) 8.4. Beyond the initial period, providers, as signatories to the SLA, may cease to provide the service by giving notice in writing to the Local Health Board. In the event of such notice, the service will be terminated 90 days after that notice is received.
Sample 1Sample 2
REVIEW VARIATION AND TERMINATION. 10.1. Variation to the service specification will only be made following consultation with Community Pharmacy Wales. 10.2. Contractors will be notified of any variations to the service specification in writing. No variation to the specification will be made until 90 days after that notice is received. 10.3. Providers, as signatories to the SLA, may cease to provide the service by giving notice in writing to the Local Health Board. In the event of such notice, the service will be terminated 90 days after that notice is received.
Sample 1
REVIEW VARIATION AND TERMINATION. 8.1. Variation to the service specification can only be made following consultation with Community Pharmacy Wales. 8.2. Contractors will be notified of any variations to the service specification in writing. No variation to the specification will be made until 90 days after that notice is received, other than where it is clinically or legally necessary to do so.
Sample 1Sample 2
REVIEW VARIATION AND TERMINATION. 10.1 This agreement will be reviewed as appropriate and may be terminated by either side giving to the other side not less than twelve months notice in writing, during which time both sides will work towards reaching a new agreement. 10.2 There shall be no variation to this agreement without a decision from the TJNCC and the LNC.
Sample 1
REVIEW VARIATION AND TERMINATION. 10.1. Variation to the service specification can only be made following consultation with Community Pharmacy Wales. 10.2. Contractors will be notified of any variations to the service specification in writing. No variation to the specification will be made until 90 days after that notice is received. 10.3. Providers, as signatories to the SLA, may cease to provide the service by giving notice in writing to the Local Health Board. In the event of such notice, the service will be terminated 90 days after that notice is received. 10.4. The Local Health Board may terminate commissioning of the service by a given provider or providers through given 90 days’ notice in writing. 10.5. Where a contractor has significantly, or repeatedly, failed to provide the service according to the above provisions, or there is significant concern regarding patient safety, the Local Health Board may terminate commissioning of the service by that provider with immediate effect.
Sample 1
REVIEW VARIATION AND TERMINATION. 6.1. The service pilot specification shall be reviewed in March 2015. 6.2. Variation to the service specification can only be made with the agreement of BCU HB, the relevant Local Authority and only following consultation with Community Pharmacy Wales. 6.3. Contractors will be notified of any variations to the service specification in writing. No variation to the specification will be made until 90 days after that notice is received. 6.4. Providers, as signatories to the SLA, may cease to provide the service by giving notice in writing to the Local Health Board. Local Health Boards will require the agreement of the relevant Area Planning Board before any notice of withdrawal of the service is served. In the event of such notice the service will be terminated 90 days after that notice is received. . Name of pharmacy contractor: Correspondence address: Postcode: Pharmacy Stamp HSW Prescribing Service Unit number: Date of application: I / We confirm that the pharmacy contractor has an acceptable system of clinical governance and is complying with any obligation under Schedule 2 to the Pharmaceutical Services Regulations to provide pharmaceutical essential services  I / We confirm that the pharmacy contractor will comply with any relevant service specification relating to the provision of this Local Enhanced Service  I / We confirm that the pharmacy contractor has a lone worker policy in place, and the pharmacists operating this service are compliant with its requirements.  I / We confirm that I / We shall notify the Medical Director of the relevant LHB of any significant adverse incident which arises due to or related to provision of this National Enhanced Service  I / we declare to the best of my/our belief that the information on this form is correct and request that the contractor named herein be included in the list of contractors who may provide this National Enhanced Service. Authorised Signature: Date: / / Name: For Office Use Only Application Checked by: Date: / / Authorised: Yes  No  Reason if not authorised: Appendix 1 – Medication Adherence Assessment Location of Assessment (circle): Home Pharmacy Surgery Hospital Other: Preferred Language (circle): Welsh English Other: GP Next of Kin/Relative Social Worker Community Pharmacy Does the patient have a carer? Yes  No  If yes, are they (circle): Formal (paid) Informal (Unpaid) Name of Care Agency/Organisation/Individual: Telephone Number: Days and time of calls (tick) Monday Tuesday Wednesday T...
Sample 1
AutoNDA by SimpleDocs
REVIEW VARIATION AND TERMINATION. It has been agreed that this document will be reviewed on an annual basis, or if any one of the signatory authorities requests an amendment. The review should also include the provision for testing the implementation procedure of the agreement.
Sample 1
REVIEW VARIATION AND TERMINATION. The service specification shall be reviewed at least annually. Variation to the service specification, Competency and Training Frameworks and Choose Pharmacy can only be made with the agreement of the Welsh Government and only following consultation with Community Pharmacy Wales. Contractors will be notified of any variations to the service specification in writing. No variation to the specification will be made until 90 days after that notice is received. Providers, as signatories to the SLA, may cease to provide the service by giving notice in writing to the Local Health Board. In the event of such notice the service will be terminated 90 days after that notice is received.
Sample 1

Related to REVIEW VARIATION AND TERMINATION

  • Modification and Termination No agreement to modify, amend, extend, supersede, terminate, or discharge this Settlement Agreement, or any portion thereof, is valid or enforceable unless it is in writing and signed by all Parties to this Settlement Agreement.

  • Duration and Termination This Agreement shall become effective with respect to each Fund as of the corresponding effective date indicated in Appendix A and, unless sooner terminated with respect to a Fund as provided herein, shall continue in effect for a period of two years as to such Fund. Thereafter, if not terminated, this Agreement shall continue in effect with respect to the Fund for successive periods of 12 months, provided such continuance is specifically approved at least annually by both (a) the vote of a majority of the Trust’s Board of Trustees or the vote of a majority of the outstanding voting securities of the Fund at the time outstanding and entitled to vote, and (b) the vote of a majority of the Trustees who are not parties to this Agreement or interested persons of any party to this Agreement, cast in person at a meeting called for the purpose of voting on such approval. Notwithstanding the foregoing, this Agreement may be terminated by the Trust at any time as to a Fund, without the payment of any penalty, upon giving the Advisor 60 days’ notice (which notice may be waived by the Advisor), provided that such termination by the Trust shall be directed or approved (x) by the vote of a majority of the Trustees of the Trust in office at the time or by the vote of the holders of a majority of the voting securities of the Fund at the time outstanding and entitled to vote, or (y) by the Advisor on 60 days’ written notice (which notice may be waived by the Trust). This Agreement will also immediately terminate in the event of its assignment. (As used in this Agreement, the terms “majority of the outstanding voting securities,” “interested person” and “assignment” shall have the same meanings of such terms in the 1940 Act.)

  • Term of Agreement and Termination 2.1. This Agreement enters into effect at the time of acceptance of this Agreement. 2.2. This Agreement will terminate without any further notice in the event products offered under this Agreement have not been used during a period of two (2) years. 2.3. This Agreement may be terminated at any time by either party with 30 days written notice. 2.4. This Agreement may be terminated by SAS with immediate effect if the Company code is used for private purposes or if SAS has reasonable cause to believe that such or similar misuse has occurred or if the Company is put into bankruptcy, enters into liquidation or is otherwise deemed to be insolvent.

  • Cancellation and Termination a) The exhibitor shall have the right to cancel this license agreement or downsize by notice in writing to be delivered to MPE. All deposits/payments received by MPE up to the date of notice of cancellation or downsize are non-refundable and non-transferable and the balance of the full cost of the space is due immediately. In the event that the Exhibitor (i) fails to make payments in accordance with the payment schedule setout herein or (ii) fails to appear at the show; MPE reserves the right to cancel this license agreement without notice and all rights of the Exhibitor hereunder shall cease and terminate. MPE will retain any and all deposits/payment(s) made by the Exhibitor as liquidated damages (and not as a penalty) for breach of this license agreement and all payments will be due per the terms of the contract. In the event of either of the above circumstances, MPE has the right to (i) re-rent said space and (ii) bring action against the Exhibitor for payment of the full cost of the space originally licensed from MPE. b) If the Exhibitor violates or breaches any other terms or conditions of this license agreement, all payments made by the Exhibitor and all amounts due to MPE shall be deemed earned by MPE and all deposits received shall be non-refundable and non-transferable. In the event of any violation or breach of the terms and conditions of this license agreement, MPE shall have the right to immediately occupy the space of the violating and/or breaching Exhibitor and utilize it in any manner as MPE deems appropriate, including, but not limited to, re-licensing its use to another exhibitor. The Exhibitor shall not be entitled to any offset or mitigation of the amount due under this license agreement as a result of the use of or payment for the space by another exhibitor in the Show. c) Each covenant by the Exhibitor contained herein is material and of the essence of this license agreement and violation of any term or condition hereof by the Exhibitor shall be a default of the entire agreement entitling MPE to immediately and without notice revoke the privileges granted to the Exhibitor and take possession of the space of the defaulting Exhibitor. Any such revocation of the license granted herein shall be without prejudice to MPE to make any claim for damages or enforcement of the payment of any amounts due pursuant to the terms hereof.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!